Charity Huang, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Roche/Genentech
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Pfizer
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Regeneron
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Amgen
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Eli Lilly
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Seagen
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Natera
    Date added: 
    09/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Theradex Oncology
    Date added: 
    09/07/2023
Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes